Summary
Overview
Work History
Education
Skills
Accomplishments
Professional Development
COMMUNITY SETVICE & ASSOCIATE ENGAGEMENT
Work Availability
Timeline
Generic

Richard Kara

Southlake,TX

Summary

Strategic-thinking director and HEOR professional experienced in global HEOR, value evidence generation, and market access operations. Over 16 years of experience in the pharmaceutical and medical device industry with expertise in market access strategies and health economics and outcomes research (HEOR). Doctorate in Public Health and Certified clinical research professional with a potent combination of strategic, technical, and operational expertise. Effective cross-functional collaborator with strong interpersonal and communication skills.

Overview

18
18
years of professional experience

Work History

Director, Global HEOR

Alcon Labs
Fort Worth, TX
07.2019 - Current
  • Developed and deploy global market access plans for new launches across 10-20 countries
  • Conceived, developed, and implemented value evidence and HEOR plans for to support launch cadence across two, three billion in revenue businesses
  • Market Access, HEOR, and reimbursement subject matter expert for multiple franchises across product development milestones (stage gates)
  • Support annual brand planning and develop value evidence-generation plans
  • Global payer and reimbursement research
  • Market access and HEOR expert during advisory board meetings
  • Lead strategic partnerships with Key Thought Leaders
  • Provide expert HEOR input into the design of clinical development programs and ensure evidence needs for country HTA/Payers are considered within the global development and commercialization strategies
  • Develop and conduct HEOR training on several evidence needs for internal stakeholders

Associate Director

WORLDWIDE HEOR, BD
Salt Lake City, UT
09.2014 - 07.2019
  • Conceived, developed, and launched HEOR function to support commercial market access and value evidence needs for CR Bard Vascular Access Devices business
  • Through insightful analysis, aggregating syndicated, specialty pharmacy and field activity data built systematic reporting tools to monitor national, field and marketing program performance for multi-channel commercial organization
  • In collaboration with the commercial finance group, provided analysis and insights to support revenue recognition and performance, forecasting and gross-to-net reporting
  • Developed HEOR and market access plans for $3.9 billion business unit.

Acting Director

BD Global Public Health, BD
Franklin Lakes, NJ
06.2018 - 10.2018
  • Management of BD Private Partnerships (CDC, Ministries of Health, etc.) engaged in global initiatives on Healthcare Work Safety, Patient Safety, and Infection Prevention.
  • Management of the BD Global Health Fellows (25): curriculum development, training, and field-based global assignments.
  • Spearheaded and traveled to Kenya to execute infection prevention initiatives across five rural district hospitals in collaboration with the local ministry of health and the Gates Foundation
  • Analyzed business opportunities and provided actionable insights on BD global health can work with R&D and product development.

Post-doctoral Fellow

Bayer Pharmaceuticals
Montville, NJ
03.2013 - 09.2014
  • Project lead responsible for developing value propositions, generating evidence and creating payer value messaging to demonstrate brand value, achieve optimal pricing and market access, and support other commercialization activities across five (5) franchises.
  • Identified potential evidence gaps (leveraging newly identified reimbursement pathways to maximize payment and access).
  • Collaborated on market shaping strategies across different portfolios, including Ophthalmology, Hematology, Oncology, Women’s Health, Cardio-Pulmonary Hypertension
  • Core team member involved in developing decision analytic tools, including burden of illness, cost-effectiveness analysis, and budgetary impact models.
  • Collected and analyzed market trends/market access hurdles and customer needs specific to health economic resources.
  • Reviewed and analyzed policies and legislation impacting Bayer and translated this into clear and meaningful messages to facilitate effective strategic management decision-making.
  • Led design and delivery of customer-facing value communication tools (e.g., value message briefs, value analysis committee presentations, budget impact models).
  • Effectively communicated HEOR deliverables at all levels, both internally and externally.
  • Core team member involved in developing Bayer’s health policy position on Women’s Health (UK) - holistic approach to women’s health across all ages and disease burdens.

Global Study Manager

Bayer Pharmaceuticals
Montville, NJ
02.2008 - 09.2014
  • Cross-functional clinical research project leader across several therapeutic areas: Ophthalmology, Hematology, Oncology, Women’s Health, and Cardio-Pulmonary Hypertension.
  • Successfully led teams to deliver quality clinical trial study outcomes on time and within budget, including delivering on highest priority studies in the clinical development plans.
  • Developed and managed study budgets ranging from $5-10 million dollars.
  • Managed strategic relationships with contract research organizations (CROs) on study planning, defining the scope of work/outsourcing specifications, study site feasibility assessments, identification and selection of relevant vendors, development of request for proposals, study start up activities including investigator meetings.
  • Developed study management processes and framework to plan, execute, measure and track the portfolio study deliverables against key performance indexes

Clinical Trials Manager

Bristol Myers Squibb
Lawrenceville, NJ
12.2006 - 02.2008
  • Managed 3-5 US clinical trials from protocol concept to the final clinical study report, including publications.
  • Worked with principal investigators and CROs to facilitate daily trial activities and comply with research protocols.
  • Co-managed, with CROs, study initiation visits and investigator meetings, implementing trials in accordance with study timelines and budgets.
  • Monitored and tracked budget commitments to the franchise, making sure to deliver on time and in budget targets.

Education

Ph.D - Public Health

Walden University
Minneapolis, MN
10.2012

Bachelor of Science - Computational Biology

Rutgers, The State University of New Jersey
10.2002

Skills

  • Value and access evidence generation
  • Global payer and reimbursement research
  • Primary & secondary evidence research
  • HEOR brand planning strategy
  • Commercial launch planning
  • Global market access strategy
  • Stakeholder HEOR value demonstration and communication tools
  • Product development stage gate planning
  • Upstream and downstream R&D and commercial support
  • KOL engagement
  • Budget planning
  • Share of voice - publications
  • Value demonstration and messaging
  • Launch cadence planning

Accomplishments

  • Conceived and built the global market access, value evidence & HEOR infrastructure for (BD/CR Bard-VAD) and two businesses at Alcon (Vitreoretinal surgery and Ocular health businesses/portfolios that comprised of developing the global market access, value, and evidence generation strategy across multiple portfolios and implementing the supporting systems, processes, tools, and insights that enabled the successful launch and/or defend priority products
  • These included global market access and reimbursement landscaping, regional evidence needs including HTA submissions, and customer facing HEOR tools for the field teams that enabled commercial team launch.

Professional Development

  • McKinsey & Company Management Accelerator Program, 2022
  • University of Pennsylvania-Wharton Online Executive Education-Marketing, 2017.
  • SHEA 2018, Certification in Antimicrobial Resistance & Infection Prevention Stewardship.
  • Rutgers Business School, New Jersey. Mini-MBA. Completed 15 graduate credits, 2009.

COMMUNITY SETVICE & ASSOCIATE ENGAGEMENT

  • Founder, Tara School Inc, a Non-Profit & Tax-Exempt organization, building schools in resource-constrained communities.
  • Winner, BD 2018 Life-Changers Award and the 2018 Henry Becton Volunteer Impact Program Award.
  • Co-Creator, BD Diversity Inclusion Week. Awarded BD Special Achievement Recognition Award.
  • Full Member, Hanover Township Board of Health (2012-2015).
  • Bayer Representative, North Jersey Health Collaborative Initiative.

Work Availability

monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse

Timeline

Director, Global HEOR

Alcon Labs
07.2019 - Current

Acting Director

BD Global Public Health, BD
06.2018 - 10.2018

Associate Director

WORLDWIDE HEOR, BD
09.2014 - 07.2019

Post-doctoral Fellow

Bayer Pharmaceuticals
03.2013 - 09.2014

Global Study Manager

Bayer Pharmaceuticals
02.2008 - 09.2014

Clinical Trials Manager

Bristol Myers Squibb
12.2006 - 02.2008

Ph.D - Public Health

Walden University

Bachelor of Science - Computational Biology

Rutgers, The State University of New Jersey
Richard Kara